Swine Pneumonia Market: Global Industry Research Report 2020-2027 | Envisage Research
Envisage report cover

Swine Pneumonia Market - By Diagnosis (Serologic Tests, PCR Tests, Others), By Treatment (Vaccination, Antibiotics, Antibacterial, Others) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 184

Status: Published

Report Code: EMR100672

Swine Pneumonia Market was valued at USD 218.6 billion in 2020, and is expected to reach USD 317.4 billion by 2027, supported by a CAGR of 9.8% during the forecast period 2020 to 2027. Pneumonia is an important disease of the lower respiratory tract that impairs animal health and lowers individual and herd performance in swine.

“Pneumonia” means inflammation of the lungs. It may be minor, subsiding quickly, or develop into advanced pneumonia. The cause of the lung inflammation and the development of complications, such as secondary bacterial infection, generally determine how severe pneumonia becomes. Coughing and “thumping” (shallow, rapid breathing) are typical symptoms of pneumonia in swine. As the pneumonia becomes more severe, appetite and growth rate decrease, feed is utilized less efficiently, hogs may become chronic poor-doers, death may occur and treatment and control costs escalate.

Swine Pneumonia Market Restraints: Lack of animal disease awareness in developing countries and high cost of vaccination hampers the swine pneumonia market.

The major key players covered in the swine pneumonia market are Merck & Co. Inc., Pfizer Inc., Elanco, Wix.com Inc., F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH., Mallinckrodt, and Sanofi among others.

Analyst Commentary

Respiratory disease in pigs has been a cause of substantial mortality and economic burden or the swine industry. Particularly, according to a statistic, swine respiratory diseases involve multiple infectious agents, and have been one of the key causes of death in nursery pigs. Various prevention strategies, notably All-In-All-Out (AIAO) swine production system in the U.S., have failed to meet the profitability expectations of the swine industry. This has invigorated research on the aetiology of pneumonic swine’s lungs—the main agent being mycoplasma hyopneumoniae.

Growing awareness about the health of swine among pork consumers has spurred research on pig's protection mechanisms, thereby encouraging the growth of the swine respiratory diseases treatment market. The primary pathogens under scanner are porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza virus, and porcine circovirus type 2. A great deal of research has come with an aim to persistence of PRRSV in swine herds in various countries.

One of the key pharmaceutical companies Boehringer Ingelheim showing interest in bringing effective control and treatment strategies for PRRSV to the market has sponsored three awards amounting to whopping $35,000. Under the aegis of Awards for Advancing Research in Respiratory Disease, researchers and practicing veterinarians, the company announced, can now apply for any one of these awards. Such initiatives no doubt promote the spirit of collaborations among researchers, thereby cementing prospects in the global swine respiratory diseases treatment market. Consequently, they help address the most pressing concerns troubling swine producers, veterinarians, and the research community at large.

Growing use of DNA metagenomic analysis tools has helped retain the rapid pace of developments in the swine respiratory diseases treatment market. Advent of relatively new approaches, such as shotgun metagenomic sequencing, opens new doors of opportunities to market players.

A few pharmaceutical companies have been sponsoring research in understanding the aetiology of porcine reproductive and respiratory syndrome. This has offered a big momentum to the swine respiratory diseases treatments. They seem to increasingly focus on infectious diseases, and resultantly expand our understanding of primary respiratory infectious agent virus as well as bacteria.

Segmentation

Global Swine Pneumonia Market By Diagnosis (Serologic Tests, PCR Test, Others), Treatment (Vaccination, Antibiotics, Antibacterial, Others), Market Type (OTC, Prescription), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027.

The countries covered in the Swine pneumonia market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Saudi Arabia, Rest of Middle East and Africa, as a part of Middle East and Africa.

Modern methods of treatment usually comprise stressing on herd diagnostics and preventative measures for swine producers. Antibiotics and vaccinations comprise key arsenal in modern management strategies in the swine respiratory diseases treatment market. Adoption of new pathogen eradication schemes have emphasized on environmental and management conditions to understand the risk factors for porcine respiratory disease complex. New treatment avenues increasingly focus on secondary or opportunistic pathogens responsible for porcine respiratory disease complex. New approaches to control disease development, notably increasing host immunity to pathogens, are likely to see good uptake among swine producers in various parts of the world.

Regional Analysis

Regions include: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Regions with substantial potential in the global swine respiratory diseases treatment market include North America, Asia Pacific except Japan (APEJ), and Europe. Particularly, in recent years, North America and APEJ have been presenting several lucrative avenues. The growth of the North America global swine respiratory diseases treatment market may be attributed to the large part to the heightened awareness of the pork industry to reduce production losses due to porcine respiratory disease complex. Also, timely vaccination for infectious disease prevention has become crucial in the regional market. In other key markets, advances in routes of administration of vaccines and antibiotic therapies have propelled growth.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Engine Powered of Suppliers
3.7.2. Bargaining Engine Powered of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Swine Pneumonia Market
Chapter 5. Global Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
5.1. Global Swine Pneumonia Market Share, By Diagnosis, 2015 - 2027 (USD Billion)
5.1.1. Serologic Tests
5.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. PCR Tests
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Others
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
6.1. Global Swine Pneumonia Market Share, By Treatment, 2015 - 2027 (USD Billion)
6.1.1. Vaccination
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. ANTIBIOTICS
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Antibacterial
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Other Vaccination Treatments
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Swine Pneumonia Market Overview, By Geography, 2015 - 2027 (USD Billion)
7.1. Global Swine Pneumonia Market Share, By Geography, 2015 - 2027 (USD Billion)
7.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
7.1.2. Market Share and CAGR Comparison, by Countries, 2020 & 2027 (%)
Chapter 8. North America Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1. North America Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
8.1.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.2. North America Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
8.1.3. North America Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
8.1.4. North America Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
8.1.4.1. U.S. Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
8.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.1.2. U.S. Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
8.1.4.1.3. Other Segments
8.1.4.2. Canada Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
8.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.2.2. Canada Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
8.1.4.2.3. Other Segments
8.1.4.3. Mexico Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
8.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
8.1.4.3.2. Mexico Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
8.1.4.3.3. Other Segments
Chapter 9. Europe Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1. Europe Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.2. Europe Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.3. Europe Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
9.1.4. Europe Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.4.1. Germany
9.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.1.2. Germany Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.4.1.3. Others Segments
9.1.4.2. France
9.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.2.2. France Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.4.2.3. Others Segments
9.1.4.3. UK
9.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.3.2. UK Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.4.3.3. Others Segments
9.1.4.4. Italy
9.1.4.4.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.4.2. Italy Swine Pneumonia Market Overview, By Diagnosis 2015 - 2027 (USD Billion)
9.1.4.4.3. Others Segments
9.1.4.5. Spain
9.1.4.5.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.4.5.2. Spain Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.4.5.3. Others Segments
9.1.4.6. Rest of Europe
9.1.4.6.1. Market size and projections, 2015 – 2025
9.1.4.6.2. Rest of Europe Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
9.1.4.6.3. Others Segments
Chapter 10. Asia Pacific Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. Asia Pacific Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. Asia Pacific Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.3. Asia Pacific Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
10.1.4. Asia Pacific Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.4.1. India
10.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.1.2. India Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.4.1.3. Other Segments
10.1.4.2. China
10.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.2.2. China Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.4.2.3. Other Segments
10.1.4.3. Japan
10.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.3.2. Japan Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.4.3.3. Other Segments
10.1.4.4. South Korea
10.1.4.4.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.4.2. South Korea Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.4.4.3. Other Segments
10.1.4.5. Rest of Asia Pacific
10.1.4.5.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.4.5.2. Rest of Asia Pacific Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
10.1.4.5.3. Other Segments
Chapter 11. Middle East & Africa Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Middle East & Africa Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Middle East & Africa Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
11.1.3. Middle East & Africa Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
11.1.4. Middle East & Africa Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.4.1. GCC
11.1.4.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.1.2. GCC Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
11.1.4.1.3. Other Segments
11.1.4.2. South Africa
11.1.4.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.2.2. South Africa Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
11.1.4.2.3. Other Segments
11.1.4.3. Rest of Middle East & Africa
11.1.4.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.4.3.2. Rest of Middle East & Africa Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
11.1.4.3.3. Other Segments
Chapter 12. South America Swine Pneumonia Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. South America Swine Pneumonia Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.2. South America Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
12.1.3. South America Swine Pneumonia Market Overview, By Treatment, 2015 - 2027 (USD Billion)
12.1.4. South America Swine Pneumonia Market Overview, By Countries, 2015- 2026 (USD Billion)
12.1.5. Brazil
12.1.5.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.5.2. Brazil Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
12.1.5.3. Other Segments
12.1.6. Argentina
12.1.6.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.6.2. Argentina Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
12.1.6.3. Other Segments
12.1.7. Rest of South America
12.1.7.1. Market size and projections, 2015 – 2027
12.1.7.2. Rest of South America Swine Pneumonia Market Overview, By Diagnosis, 2015 - 2027 (USD Billion)
12.1.7.3. Other Segments
Chapter 13. Competitive Landscape
13.1. Competitive environment, 2020
13.2. Strategic framework
13.2.1. Partnership/agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Distribution channel development
Chapter 14. Key Vendor Analysis
14.1. Merck & Co. Inc.
14.1.1. Company overview
14.1.2. Financial performance
14.1.3. Distribution channel Benchmarking
14.1.4. Recent initiatives
14.1.5. SWOT analysis
14.2. Pfizer Inc
14.2.1. Company overview
14.2.2. Financial performance
14.2.3. Distribution channel Benchmarking
14.2.4. Recent initiatives
14.2.5. SWOT analysis
14.3. Elano
14.4. Wix.com Inc
14.5. F. Hoffmann-La Roche Ltd
14.6. Boehringer Ingelheim International GmbH
14.7. Mallinckrodt
14.8. Sanofi
Chapter 15. Swine Pneumonia Market Cost Analysis
15.1. Swine Pneumonia Market Key Raw Material Analysis
15.1.1. Key Raw Material
15.1.2. Price Trend of Key Raw Material
15.1.3. Key Suppliers of Raw Material
15.1.4. Market Concentration Rate of Raw Material
Chapter 16. Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1. Swine Pneumonia Market Industrial Chain Analysis
16.2. Upstream Raw Material Sourcing
16.3. Raw Material Source of Swine Pneumonia Market Major Manufacturers in 2021
16.4. Downstream Buyers
Chapter 17. Marketing Strategy Analysis, Distributors/Traders
17.1. Marketing Channel
17.1.1. Direct Marketing
17.1.2. Indirect Marketing
17.1.3. Marketing Channel Development Trend
17.2. Market Positioning
17.2.1. Pricing Strategy
17.2.2. Brand Strategy
17.2.3. Target Antibiotics
17.3. Distributors/Traders List
Chapter 18. Market Effect Factors Analysis
18.1. Technology Progress/Risk
18.1.1. Substitutes Threat
18.1.2. Technology Progress in Related Distribution channel
18.2. Consumer Needs/Customer Preference Change
18.3. Economic/Political Environmental Change
Chapter 19. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Engine Powered of Suppliers
5. Engine Powered of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Swine Pneumonia Market share, By Diagnosis, 2020 & 2027 (%)
10. Global Swine Pneumonia Market share, by Serologic Tests, By Diagnosis, 2020 & 2027 (USD Billion)
11. Global Swine Pneumonia Market share, by PCR Tests (AML), By Diagnosis, 2020 & 2027 (USD Billion)
12. Global Swine Pneumonia Market share, by Others, By Diagnosis, 2020 & 2027 (USD Billion)
13. Global Swine Pneumonia Market share, By Treatment, 2020 & 2027 (%)
14. Global Swine Pneumonia Market share, by ANTIBIOTICS, By Treatment, 2020 & 2027 (USD Billion)
15. Global Swine Pneumonia Market share, by Vaccination, By Treatment, 2020 & 2027 (USD Billion)
16. Global Swine Pneumonia Market share, by Antibacterial, By Treatment, 2020 & 2027 (USD Billion)
17. Global Swine Pneumonia Market share, by Other Vaccination Treatments, By Treatment, 2020 & 2027 (USD Billion)
18. Global Swine Pneumonia Market share, by Region, 2020 & 2027 (%)
19. Global Swine Pneumonia Market share, by region, 2020 - 2027(USD Billion)
20. North America Swine Pneumonia Market, 2020 - 2027(USD Billion)
21. North America Swine Pneumonia Market share, by Countries, 2020 & 2027 (%)
22. U.S. Swine Pneumonia Market, 2020 - 2027(USD Billion)
23. Canada Swine Pneumonia Market, 2020 - 2027(USD Billion)
24. Europe Swine Pneumonia Market, 2020 - 2027(USD Billion)
25. Europe Swine Pneumonia Market share, by Countries, 2020 & 2027 (%)
26. Spain Swine Pneumonia Market, 2020 - 2027(USD Billion)
27. UK Swine Pneumonia Market, 2020 - 2027(USD Billion)
28. Italy Swine Pneumonia Market, 2020 - 2027(USD Billion)
29. Germany Swine Pneumonia Market, 2020 - 2027(USD Billion)
30. France Swine Pneumonia Market, 2020 - 2027(USD Billion)
31. Rest of Europe Swine Pneumonia Market, 2020 - 2027(USD Billion)
32. Asia-Pacific Swine Pneumonia Market, 2020 - 2027(USD Billion)
33. Asia-Pacific Swine Pneumonia Market share, by Countries, 2020 & 2027 (%)
34. China Swine Pneumonia Market, 2020 - 2027(USD Billion)
35. India Swine Pneumonia Market, 2020 - 2027(USD Billion)
36. Australia Swine Pneumonia Market, 2020 - 2027(USD Billion)
37. Japan Swine Pneumonia Market, 2020 - 2027(USD Billion)
38. Rest of Asia-Pacific Swine Pneumonia Market, 2020 - 2027(USD Billion)
39. Middle East & Africa Swine Pneumonia Market, 2020 - 2027(USD Billion)
40. Middle East & Africa Swine Pneumonia Market share, by Countries, 2020 & 2027 (%)
41. GCC Swine Pneumonia Market, 2020 - 2027(USD Billion)
42. South Africa Swine Pneumonia Market, 2020 - 2027(USD Billion)
43. Rest Of Middle East & Africa Swine Pneumonia Market, 2020 - 2027(USD Billion)
44. South America Swine Pneumonia Market, 2020 - 2027(USD Billion)
45. Brazil Swine Pneumonia Market, 2020 - 2027(USD Billion)
46. Mexico Swine Pneumonia Market, 2020 - 2027(USD Billion)
47. Argentina Swine Pneumonia Market, 2020 - 2027(USD Billion)
48. Rest Of South America Swine Pneumonia Market, 2020 - 2027(USD Billion)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Swine Pneumonia Market, 2020-2027 (USD Billion)
4. Swine Pneumonia requirement, by country, 2020-2027, (USD Billion)
5. North America Swine Pneumonia Market, By Diagnosis, 2020-2027 (USD Billion)
6. North America Swine Pneumonia Market, By Treatment, 2020-2027 (USD Billion)
7. Europe Swine Pneumonia Market, By Diagnosis, 2020-2027 (USD Billion)
8. Europe Swine Pneumonia Market, By Treatment, 2020-2027 (USD Billion)
9. Asia Pacific Swine Pneumonia Market, By Diagnosis, 2020-2027 (USD Billion)
10. Asia Pacific Swine Pneumonia Market, By Treatment, 2020-2027 (USD Billion)
11. Middle East & Africa Swine Pneumonia Market, By Diagnosis, 2020-2027 (USD Billion)
12. Middle East & Africa Swine Pneumonia Market, By Treatment, 2020-2027 (USD Billion)
13. South America Swine Pneumonia Market, By Diagnosis, 2020-2027 (USD Billion)
14. South America Swine Pneumonia Market, By Treatment, 2020-2027 (USD Billion)
15. Global Swine Pneumonia Market, Company Market Share, 2020 & 2027(%)
16. Merck & Co. Inc.,: Product Benchmarking
17. Merck & Co. Inc.,: Financial Performance
18. Pfizer Inc.,: Product Benchmarking
19. Pfizer Inc.,: Financial Performance
20. Elano: Product Benchmarking
21. Elano: Financial Performance
22. Wix.com Inc.,: Product Benchmarking
23. Wix.com Inc.,: Financial Performance
24. F. Hoffmann-La Roche Ltd.,: Product Benchmarking
25. F. Hoffmann-La Roche Ltd.,: Financial Performance
26. Boehringer Ingelheim International GmbH: Product Benchmarking
27. Boehringer Ingelheim International GmbH: Financial Performance
28. Mallinckrodt: Product Benchmarking
29. Mallinckrodt: Financial Performance
30. Sanofi: Product Benchmarking
31. Sanofi: Financial Performance

The Leading Key Players in Swine Pneumonia Market

Merck & Co. Inc.
Pfizer Inc.
Elanco
Wix.com Inc.
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim International GmbH.
Mallinckrodt
Sanofi